Latest news
Symposium series | Optimizing treatment for chronic lymphocytic leukemia with BTK inhibitors - lymphomahub.comlymphomahub.com · Fri, 07 Aug 2026 19:18:15 GMTAcalabrutinib May Offer Durable Results in CLL Treatment - MedscapeMedscape · Fri, 07 Aug 2026 13:09:21 GMTHundreds to benefit from new treatment option for mantle cell lymphoma and chronic lymphocytic leukaemia - Wired-GovWired-Gov · Thu, 06 Aug 2026 16:17:41 GMTNICE Expands First-Line Options for Two Blood Cancers - MedscapeMedscape · Thu, 06 Aug 2026 11:51:08 GMTNICE recommends new treatment for Mantle Cell Lymphoma and Chronic Lymphocytic Leukaemia - National Health ExecutiveNational Health Executive · Thu, 06 Aug 2026 09:32:12 GMTProfile of Lymphocytic and Granulocytic Activities in Senegalese Patients with Atopic Dermatitis According to Disease Duration - SCIRP Open AccessSCIRP Open Access · Thu, 06 Aug 2026 07:26:18 GMTNurix Phase 3 Trial Tests Bexobrutideg Against CLL Standard of Care - Stock TitanStock Titan · Tue, 04 Aug 2026 05:03:02 GMTBTK Inhibitors in Chronic Lymphocytic Leukemia: Current Practice and Future Perspectives - OncodailyOncodaily · Mon, 03 Aug 2026 00:05:55 GMT